These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2948307)

  • 1. In vitro immunosuppressive properties of cyclosporine metabolites.
    Freed BM; Rosano TG; Lempert N
    Transplantation; 1987 Jan; 43(1):123-7. PubMed ID: 2948307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive metabolites of cyclosporine in the blood of renal allograft recipients.
    Rosano TG; Freed BM; Cerilli J; Lempert N
    Transplantation; 1986 Sep; 42(3):262-7. PubMed ID: 2944258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic and antagonistic effects of combinations of cyclosporine A and its metabolites on inhibition of phytohemagglutinin-induced lymphocyte transformation in vitro.
    Schultz JC; Lensmeyer GL; Wendal TD; Shahidi NT; Wiebe DA; Carlson IH
    Biochem Pharmacol; 1991 Sep; 42(7):1403-10. PubMed ID: 1834063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo comparative studies on immunosuppressive properties of cyclosporines A, C, D and metabolites M1, M17 and M21.
    Sadeg N; Pham-Huy C; Rucay P; Righenzi S; Halle-Pannenko O; Claude JR; Bismuth H; Duc HT
    Immunopharmacol Immunotoxicol; 1993; 15(2-3):163-77. PubMed ID: 8349948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of activated human lymphocytes to cyclosporine and its metabolites.
    Zeevi A; Venkataramanan R; Burckart G; Wang CP; Murase N; Van Thiel DH; Starzl TE; Makowka L; Duquesnoy RJ
    Hum Immunol; 1988 Feb; 21(2):143-53. PubMed ID: 2966788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cyclosporine metabolites M17 and M18 on proliferation and interleukin 2 production in the mixed lymphocyte culture.
    Freed BM; Rosano TG; Quick C; Lempert N
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1223-6. PubMed ID: 2950629
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-allergic activity of cyclosporin-A metabolites and their interaction with the parent compound and FK 506.
    Ezeamuzie CI
    Int J Immunopharmacol; 1996 Apr; 18(4):263-70. PubMed ID: 8894806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the production of a soluble helper mediator by cyclosporin A results in the failure to generate alloreactive cytolytic cells in mixed-lymphocyte culture.
    Wang BS; Zheng CX; Heacock EH; Tilney NL; Strom TB; Mannick JA
    Clin Immunol Immunopathol; 1983 May; 27(2):160-9. PubMed ID: 6223754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive and synergistic effects of cyclosporine metabolites on glomerular mesangial cells.
    Radeke HH; Christians U; Bleck JS; Sewing KF; Resch K
    Kidney Int; 1991 Jun; 39(6):1255-66. PubMed ID: 1895678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of cyclosporine and metabolite binding to cyclophilin and a 50 kDa binding protein with in vitro immunosuppression: a preliminary report.
    Donnelly JG; Russell RL; Palaszynski EW; Copeland KR; Yatscoff RW; Chan MM; Soldin SJ
    Clin Biochem; 1991 Feb; 24(1):71-4. PubMed ID: 2060135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of interleukin 2 on the immunosuppressive action of cyclosporine.
    Hess AD
    Transplantation; 1985 Jan; 39(1):62-8. PubMed ID: 3155579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cyclosporine, cyclosporine metabolite 17, and other cyclosporine-related compounds on T lymphocyte clones derived from rejected human kidney grafts. I. Inhibition of proliferation.
    Chabannes D; Moreau JF; Soulillou JP
    Transplantation; 1987 Dec; 44(6):813-7. PubMed ID: 3321590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of proliferative responses and interleukin 2 productions by salazosulfapyridine and its metabolites.
    Fujiwara M; Mitsui K; Yamamoto I
    Jpn J Pharmacol; 1990 Oct; 54(2):121-31. PubMed ID: 1981793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin A metabolites suppress T-cell proliferation by concanavalin A and in a mixed lymphocyte reaction.
    Abecassis M; Wong PY; Mason N; Cheung F; Mee AV; Cole EH; Langer B; Cohen Z; Levy GA
    Can J Surg; 1988 May; 31(3):145-50. PubMed ID: 2966666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway.
    Pereira GM; Miller JF; Shevach EM
    J Immunol; 1990 Mar; 144(6):2109-16. PubMed ID: 1968924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine polyclonal T-lymphocyte activation induced by phytohemmagglutinin; differential lymphokine requirements of two unusual activation pathways defined by resistance to blockade by barium and by cyclosporin A.
    Peçanha LM; Dos Reis GA
    Int J Immunopharmacol; 1989; 11(2):149-56. PubMed ID: 2649443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin A inhibits IL 2-driven proliferation of human alloactivated T cells.
    Buurman WA; Ruers TJ; Daemen IA; van der Linden CJ; Groenewegen G
    J Immunol; 1986 Jun; 136(11):4035-9. PubMed ID: 2939138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro comparative study on nephrotoxicity of cyclosporine A, its metabolites M1, M17, M21, and its analogues cyclosporines C and D in suspensions of rabbit renal cortical cells.
    Sadeg N; Pham-Huy C; Martin C; Warnet JM; Claude JR
    Drug Chem Toxicol; 1994; 17(2):93-111. PubMed ID: 7914868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclosporins inhibit lymphocyte activation at more than one site.
    Gelfand EW; Cheung RK; Mills GB
    J Immunol; 1987 Feb; 138(4):1115-20. PubMed ID: 3492542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effect of cyclosporine on the nuclear proliferative response to a variety of T cell activators.
    Citterio F; Kahan BD
    Transplantation; 1989 Feb; 47(2):334-8. PubMed ID: 2521963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.